C&R Research Inc
359090
Company Profile
Business description
C&R Research Inc provides a quotation on clinical trial service. The company is a contract research organization specializing in clinical trial design, consulting, monitoring, data management, and licensing for clients like pharmaceutical companies and biotech ventures.
Contact
412 Yeoksam-ro
C&R Building
Gangnam-gu
Seoul
KORT: +82 262511500
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
31 December 2026
Employees
526
Stocks News & Analysis
stocks
Chart of the Week: Inflation fears dampen sentiment on retailers
Rising inflation is the fly in the ointment.
stocks
Here’s 3 Top Rated ASX shares for 2026
As we start the new year, let’s take a closer look at three compelling opportunities on the ASX
stocks
Undervalued Aussie e-commerce winner
Shares attractive due to near term profit margin increase and structural growth.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,044.70 | 5.20 | 0.06% |
| CAC 40 | 8,233.92 | 3.51 | -0.04% |
| DAX 40 | 25,122.26 | 230.06 | 0.92% |
| Dow JONES (US) | 48,996.08 | 466.00 | -0.94% |
| FTSE 100 | 10,048.21 | 74.52 | -0.74% |
| HKSE | 26,085.98 | 624.47 | -2.34% |
| NASDAQ | 23,584.28 | 37.10 | 0.16% |
| Nikkei 225 | 51,660.50 | 857.58 | -1.63% |
| NZX 50 Index | 13,707.93 | 7.09 | -0.05% |
| S&P 500 | 6,920.93 | 23.89 | -0.34% |
| S&P/ASX 200 | 8,719.60 | 3.90 | -0.04% |
| SSE Composite Index | 4,081.47 | 4.31 | -0.11% |